✦ LIBER ✦

PO10-TU-50 Hungarian long term experience of natalizumab in multiple sclerosis patients from clinical trials

✍ Scribed by T. Csepany; J. Sikula; G. Jakab; A. Guseo; G. Rum; A. Csanyi; J. Matolcsi; C. Rozsa; E. Dobos; P. Harcos; J. Kanya; P. Dioszeghy; L. Csiba; S. Komoly

Book ID: 119468148
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 285
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(09)70799-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO10-TU-30 Patient-rated suitability of

PO10-TU-30 Patient-rated suitability of a new electronic device for subcutaneous injection of interferon beta-1a in relapsing multiple sclerosis: results from an international, multicentre, single-arm, open-label, twelve week, Phase IIIb trial

✍ V. Devonshire; E. Verdun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term safety experience of ustekinum

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials

✍ Mark Lebwohl; Craig Leonardi; Christopher E.M. Griffiths; Jörg C. Prinz; Philipp 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Long-term safety experience of ustekinum

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

✍ Kenneth B. Gordon; Kim A. Papp; Richard G. Langley; Vincent Ho; Alexa B. Kimball 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 422 KB